Dr. David Page is a medical oncologist and clinical investigator at the Providence Cancer Institute in Portland, Oregon. His area of expertise is in the field of breast cancer immunotherapy. 

He completed a Bachelor’s of the Arts at the University of Chicago, a medical doctorate at Northwestern University, followed by internal medicine residency at Columbia University / New York Presbyterian and medical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City. 

He has conducted and published outcomes of numerous investigator-initiated trials, including trials combining immune checkpoint blockade with chemotherapy, radiotherapy, and novel targeted/immune therapies in breast cancer, both in the curative and metastatic setting. He also has served on various immunotherapy-related committees, including the NCI Breast Immuno-oncology task force, the SITC Breast Immunotherapy expert panel, and the SITC multispectral immunoflourescence working group.